Astero Product

Astero® is the first FDA-approved prescription combination drug-device hydrogel containing Lidocaine HCl 4% for associated wound pain, healing and vasculitis. Available by prescription only, Astero® provides superior wound healing and has a rapid onset of action in 3-5 minutes. Clinicians, treating patients with wounds, concerned with wound pain management should consider Astero® as the first choice in wound therapy.

Astero® Indications for Use:

Indicated for the relief of painful wounds and wound healing such as:

  • Closed wound/non-penetrating
    • Soft tissue injuries and bony contusions secondary to contusions, hematomas, crush injuries, and sprains/strains due to torsion, traction, compression and tearing
    • Trauma
    • Acute and chronic wounds of various etiologies
    • Associated topical pain
      • Post-surgical incisions
  • Open wound for pain and healing
    • Acute and chronic ulcerations
    • Chronic mixed vascular etiologies
    • Diabetic ulcers
    • Arterial and venous stasis ulcers
    • Decubitus ulcers
    • Pressure wounds
  • Vasculitis
  • First and second degree burns
  • Severe to mild cuts and abrasions, lacerations and puncture wounds

A Combination Drug-Device Hydrogel Containing Lidocaine HCl 4% for Associated Wound Pain, Healing and Vasculitis

The only FDA-approved prescription combination drug-device containing 4% Lidocaine HCl in a hydrogel that provides the relief of pain associated with Closed Skin, Non-Penetrating and Open Wounds, as well as a treatment for wound healing and vasculitis.

Accurate Dosing

Astero® 30mL (120 Doses)

Apply to the affected area as directed. Maximum 12 pumps per day.

Metered Dose Technology (MDose™) dispenses the exact amount of medication. 1 pump = 1 dose (0.25 mL/pump).

Fast Acting

Astero® provides fast pain relief with an onset of action within 3-5 minutes. Each pump is a measured dose for simple adherence.

  • Launched in May 2016
  • Available by prescription only
  • Astero® is available in 30 mL bottles
  • NDC 35781-2500-3

All Gensco® products, including Astero®, are distributed to pharmacy chains such as Walgreens®, CVS®, Walmart®, RiteAid®, Kroger® and Publix® through the major wholesalers such as McKesson, Cardinal and AmerisourceBergen. Astero® is contracted with DAPA (Contract #SP0200-15-H-0003), Federal Supply Schedule (FSS) (Contract #V797D-70219), making it accessible to all military personnel and is also available to all MEDICARE patients (Medicare Contract #P1466). Astero® is available through these Group Purchasing Organizations (GPOs): Intalere, Innovatix, MedAssets, Premier, MHA, ROi and Vizient.

Astero® 30mL Bottles (120 Doses) | NDC 35781-2500-3


Review and Case Study of AsteroFEATURED:

Published in Podiatry Management, November 2016
A Review and Case Study of Astero (Lidocaine HCl 4%):
A New Prescription Hydrogel for Painful Wounds

by Marc Alan Brenner, DPM | The Institute for Diabetic

Wound pain has numerous, often interlinked, causes that
may relate to the initial injury, the inflammatory response or
infection.  more…

Published in Podiatry Management, August 2016
Advances in the Treatment of Painful Wounds
by Marc Alan Brenner, DPM | The Institute for Diabetic

Wound management is one of the most common aspects of podiatric practice.  more…


Antimicrobial Properties of LiDORx® August 8, 2017 Clinical, Featured, Research - Antimicrobial Properties of LiDORx® Research Report[1] Assessment of LiDORx® Antimicrobial Activity Against Common Skin Pathogens By: Robert L. Wilbur, PharmD, more...

Looking To The Future

A single dose topical colchinium for acute gout flares.
LidoDose Logo
A single dose topical anesthetic for injections and vaccines.
See all news